PDL BioPharma, Inc. Financing Receivable, after Allowance for Credit Loss, Noncurrent
PDL BioPharma, Inc. had Financing Receivable, after Allowance for Credit Loss, Noncurrent of $636.00 thousand as of 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments and Receivables, Net › Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent › Financing Receivable, after Allowance for Credit Loss, Noncurrent
us-gaap:NotesAndLoansReceivableNetNoncurrent · last filed 2021-03-29
- 2020-06-30: Financing Receivable, after Allowance for Credit Loss, Noncurrent $636.00K.
- 2020-03-31: Financing Receivable, after Allowance for Credit Loss, Noncurrent $722.00K.
- 2019-12-31: Financing Receivable, after Allowance for Credit Loss, Noncurrent $827.00K.
- 2019-09-30: Financing Receivable, after Allowance for Credit Loss, Noncurrent $691.00K.
| Period end | Financing Receivable, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2020-06-30 | $636.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $722.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $827.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $691.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $547.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $648.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $771.00K 8-K · filed 2020-06-29 |
| 2018-09-30 | $10.69M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $12.83M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $14.97M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $17.12M 10-K · filed 2019-03-15 |
| 2017-09-30 | $13.09M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $154.83M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $157.40M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $159.77M 10-K · filed 2018-03-16 |
| 2016-09-30 | $189.87M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $276.82M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $287.24M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $306.51M 10-K · filed 2017-03-01 |
| 2015-09-30 | $286.16M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $304.91M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $302.37M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $305.62M 10-K · filed 2016-02-23 |
| 2014-09-30 | $363.29M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $413.72M 10-Q · filed 2014-08-18 |
| 2014-03-31 | $247.20M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $193.84M 10-K · filed 2015-02-23 |
| 2013-09-30 | $90.81M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $110.59M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $45.50M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $85.70M 10-K · filed 2014-03-03 |
| 2012-09-30 | $33.49M 10-Q · filed 2012-11-05 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-01 |